Literature DB >> 11788428

Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.

Thorsten Reffelmann1, Sharon L Hale, Guohu Li, Robert A Kloner.   

Abstract

No reflow after acute myocardial infarction is an important predictor of infarct size and clinical outcome. However, the exact relationship between no reflow and infarct size remains to be determined, particularly because no reflow may progress during the time course of reperfusion. Control groups of five previous protocols using the anesthetized, open-chest rabbit model of coronary artery occlusion and reperfusion were retrospectively analyzed with respect to the correlation between regional myocardial blood flow (RMBF; radioactive microspheres) and infarct size (triphenyltetrazolium chloride) in the course of reperfusion. After 30 min of occlusion, reflow (defined as the ratio of RMBF in the risk area divided by the nonischemic area) declined from hyperemic values after 30 min of reperfusion (reflow ratio: 1.33 +/- 0.81; RMBF in the risk area at the same time point: 2.25 +/- 1.04 ml x g(-1) x min(-1)) to 0.47 +/- 0.22 after 120 min and 0.46 +/- 0.13 after 180 min of reperfusion. After 120 min of ischemia, reflow at 30 min of reperfusion was 0.49 +/- 0.24 and deteriorated by 120 min of reperfusion (0.26 +/- 0.15). In every group, there was a strong correlation between infarct size and reflow (correlation coefficients: -0.62 to -0.82). The lines of regression for the groups with assessment of RMBF after 120 or 180 min of reperfusion were nearly identical regardless of the duration of ischemia. Thus microvascular reperfusion injury led to a striking decrease in RMBF within the first 2 h of reperfusion, with infarct size as the major determinant of reflow at a given time point of reperfusion.

Entities:  

Mesh:

Year:  2002        PMID: 11788428     DOI: 10.1152/ajpheart.00767.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.

Authors:  Stavros Stavrakis; John Terrovitis; Elias Tsolakis; Stavros Drakos; Argirios Dalianis; Michael Bonios; Dimitrios Koudoumas; Konstantinos Malliaras; John Nanas
Journal:  J Cardiovasc Transl Res       Date:  2010-12-09       Impact factor: 4.132

Review 2.  Coronary vasoregulation in health and disease.

Authors:  John G Kingma; Jacques R Rouleau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

Review 3.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

4.  Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study.

Authors:  Agnes Mayr; Kathrin Pedarnig; Gert Klug; Michael Schocke; Otmar Pachinger; Werner Jaschke; Bernhard Metzler
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-01       Impact factor: 2.357

5.  Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography.

Authors:  Gunnar Frostfeldt; Jens Sörensen; Bertil Lindahl; Sven Valind; Lars Wallentin
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

6.  Human epicardial cell-conditioned medium contains HGF/IgG complexes that phosphorylate RYK and protect against vascular injury.

Authors:  Krithika S Rao; Alexander Aronshtam; Keara L McElory-Yaggy; Benjamin Bakondi; Peter VanBuren; Burton E Sobel; Jeffrey L Spees
Journal:  Cardiovasc Res       Date:  2015-05-29       Impact factor: 10.787

7.  MRI manifestations of persistent microvascular obstruction and acute left ventricular remodeling in an experimental reperfused myocardial infarction.

Authors:  Yuesong Yang; John J Graham; Kim Connelly; Warren D Foltz; Alexander J Dick; Graham A Wright
Journal:  Quant Imaging Med Surg       Date:  2012-03

8.  Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.

Authors:  Jennifer L Strande; Michael E Widlansky; Nikos E Tsopanoglou; Jidong Su; JingLi Wang; Anna Hsu; Kasi V Routhu; John E Baker
Journal:  Cardiovasc Res       Date:  2009-04-20       Impact factor: 10.787

9.  Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids.

Authors:  Hiroshi Irie; Irvin B Krukenkamp; Joep F F Brinkmann; Glenn R Gaudette; Adam E Saltman; William Jou; Jan F C Glatz; Nada A Abumrad; Azeddine Ibrahimi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-13       Impact factor: 11.205

10.  Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trial.

Authors:  Vinod Jorapur; Terje K Steigen; Christopher E Buller; Vladimír Dzavík; John G Webb; Bradley H Strauss; Eunice E S Yeoh; Peter Kurray; Leszek Sokalski; Mauricio C Machado; Shari S Kronsberg; Gervasio A Lamas; Judith S Hochman; G B John Mancini
Journal:  Catheter Cardiovasc Interv       Date:  2008-11-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.